M.D. Waterfield
Impact in
- Cell Biology top 1%
- Cellular transport and secretion
- Molecular Biology top 2%
- Protein Kinase Regulation and GTPase Signaling
- PI3K/AKT/mTOR signaling in cancer
- Glycosylation and Glycoproteins Research
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 12
- Glycosylation and Glycoproteins Research 7
- PI3K/AKT/mTOR signaling in cancer 6
- Oncology 12
- HER2/EGFR in Cancer Research 6
- Cytokine Signaling Pathways and Interactions 3
- Co-authors
- Peter J. Parker (7 shared papers)Julian Downward (3 shared papers)Ivan Gout (8 shared papers)Bart Vanhaesebroeck (3 shared papers)J. Domin (1 shared paper)Patricia H. Warne (1 shared paper)Pablo Rodriguez‐Viciana (1 shared paper)Silvia Stabel (1 shared paper)
- Journals
- The EMBO Journal (10 papers)Journal of Biological Chemistry (6 papers)PROTEOMICS (2 papers)Protein Science (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United KingdomBelgiumJapan
In The Last Decade
M.D. Waterfield
45 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 126
- Cell Biology 857
- Molecular Biology 3.5k
- Immunology and Allergy 263
- Immunology 685
- Oncology 861
Countries citing papers authored by M.D. Waterfield
This map shows the geographic impact of M.D. Waterfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.D. Waterfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.D. Waterfield more than expected).
Fields of papers citing papers by M.D. Waterfield
This network shows the impact of papers produced by M.D. Waterfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.D. Waterfield. The network helps show where M.D. Waterfield may publish in the future.
Co-authors
The 25 scholars most cited alongside M.D. Waterfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 480 | |
| 2 | 1996 | 479 | |
| 3 | 1985 | 282 | |
| 4 | 1984 | 255 | |
| 5 | 1985 | 245 | |
| 6 | 1992 | 225 | |
| 7 | 1986 | 219 | |
| 8 | 1993 | 213 | |
| 9 | 1997 | 203 | |
| 10 | 1985 | 190 | |
| 11 | 2006 | 164 | |
| 12 | 1984 | 141 | |
| 13 | 1988 | 140 | |
| 14 | 1994 | 135 | |
| 15 | 1992 | 112 | |
| 16 | 1994 | 107 | |
| 17 | 1988 | 97 | |
| 18 | 2004 | 91 | |
| 19 | Phosphatidylinositol 3-kinase: a novel effector. | 1992 | 91 |
| 20 | 1996 | 81 |
About M.D. Waterfield
M.D. Waterfield is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Cell Biology and Spectroscopy, having authored 45 papers that have together received 4.8k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (12 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (7 papers), Cellular transport and secretion (7 papers), HER2/EGFR in Cancer Research (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Advanced Proteomics Techniques and Applications (5 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Cell Biology (857 citations), Molecular Biology (3.5k citations), Immunology and Allergy (263 citations), Immunology (685 citations) and Oncology (861 citations). M.D. Waterfield has collaborated with scholars based in United Kingdom, Belgium and Japan. Frequent co-authors include Peter J. Parker, Julian Downward, Ivan Gout, Bart Vanhaesebroeck, J. Domin, Patricia H. Warne, Pablo Rodriguez‐Viciana, Silvia Stabel, E. L. V. Mayes and Nicholas F. Totty. Their work appears in journals such as The EMBO Journal, Journal of Biological Chemistry, PROTEOMICS, Protein Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.